Medacta Group SA

MOVE

CH0468525222

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange Other stock markets 11:30:46 2024-05-14 am EDT			5-day change	1st Jan Change
118.8 ^CHF	+2.41%		+3.66%	-5.41%

Mar. 13	Medacta Group SA Proposes Distribution	CI
Mar. 13	Medacta Group SA Provides Earnings Guidance for the Year 2024	CI

Medacta Group SA Revises Revenue Growth Guidance for the Full Year 2022

September 09, 2022 at 01:00 am EDT

Medacta Group SA revised upward 2022 revenue growth guidance in the range of 14% to 16%, at constant currency. This compares to previous outlook of revenue growth towards 14%.

Latest news about Medacta Group SA

Medacta Group SA Proposes Distribution	Mar. 13	CI
Medacta Group SA Provides Earnings Guidance for the Year 2024	Mar. 13	CI
Transcript : Medacta Group SA, 2023 Earnings Call, Mar 13, 2024	Mar. 13
Medacta Group Records Higher FY23 Attributable Profit, Revenue	Mar. 13	MT
Medacta Group SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 12	CI
Medacta Enters Collaboration for RFID Technology in Healthcare Business	Feb. 20	MT
Transcript : Medacta Group SA, 2023 Sales/ Trading Statement Call, Feb 02, 2024	Feb. 02
Medacta Group Books 17% Jump in FY23 Revenue	Feb. 02	MT
Medacta to Expand Swiss Facilities to Boost Production Capacity	Nov. 30	MT
Medacta Group to Launch Optimized Knee Implant	23-10-30	MT
Medacta's New Study Shows Accuracy of NextAR Shoulder Application	23-10-13	MT
Transcript : Medacta Group SA, Q2 2023 Earnings Call, Sep 22, 2023	23-09-22
Medacta Group Reports Higher H1 Attributable Profit, Revenue	23-09-22	MT
Medacta Group SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-20	CI
Transcript : Medacta Group SA, H1 2023 Sales/ Trading Statement Call, Jul 28, 2023	23-07-28
Medacta Posts 21% Increase in H1 Revenue; Raises FY23 Guidance	23-07-28	MT
Medacta Group SA Announces Unaudited Revenue Results for the First Half Ended June 30, 2023	23-07-28	CI
Medacta Group SA Updates Revenue Guidance for the Year 2023	23-07-28	CI
Global markets live: Enel, ASML, Adobe, Nikola...	23-07-05
Medacta Group Completes First MyPAO Surgery in Europe	23-07-04	MT
Exclusive-EQT sounds out banks to manage LimaCorporate IPO - sources	23-05-03	RE
Medacta Group SA Approves Distribution for the Year 2022	23-04-27	CI
Medacta's MySpine Platform Shows Accuracy for Pedicle Screw Placement in Clinical Study	23-03-21	MT
Medacta Group SA Provides Earnings Guidance for the Year 2023	23-03-17	CI
Medacta Group SA Proposes Dividend	23-03-17	CI

Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-16 - Mirabaud Swiss Equity Conference

More about the company

Income Statement Evolution

More financial data

Ratings for Medacta Group SA

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

118.4 EUR

Average target price

147 EUR

Spread / Average Target

+24.13%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
MEDACTA GROUP SA	-5.41%	2.55B
ABBOTT LABORATORIES	-5.97%	182B
MEDTRONIC PLC	+1.66%	111B
BECTON, DICKINSON AND COMPANY	-3.70%	68.48B
DEXCOM, INC.	+0.48%	49.69B
CENCORA, INC.	+7.58%	44.46B
HOYA CORPORATION	+2.33%	40.67B
METTLER-TOLEDO INTERNATIONAL, INC.	+22.52%	31.22B
WEST PHARMACEUTICAL SERVICES, INC.	+1.34%	26.09B
TERUMO CORPORATION	+15.30%	25.32B

Other Medical Equipment, Supplies & Distribution

Medacta Group SA

Equities

MOVE

CH0468525222

Medical Equipment, Supplies & Distribution

Medacta Group SA Revises Revenue Growth Guidance for the Full Year 2022

Latest news about Medacta Group SA

Chart Medacta Group SA

Company Profile

Income Statement Evolution

Ratings for Medacta Group SA

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution